| WGS Genedx Holdings Corp. | 18.03% | 3,507,164 | $269.6M | No change |
| BLFS Biolife Solutions Inc. | 15.11% | 8,707,165 | $226.0M | No change |
| RVMD Revolution Medicines Inc. | 10.82% | 3,699,283 | $161.8M | Reduce -10.1% |
| SRPT Sarepta Therapeutics Inc. | 8.73% | 1,073,500 | $130.5M | No change |
| LAB Standard Biotools Inc. | 8.34% | 71,254,677 | $124.7M | No change |
| ILMN Illumina Inc. | 6.70% | 750,000 | $100.2M | No change |
| RNAM Avidity Biosciences Inc. | 3.98% | 2,045,000 | $59.5M | Reduce -1.9% |
| CDXS Codexis Inc. | 2.58% | 8,100,000 | $38.6M | No change |
| RLAY Relay Therapeutics Inc. | 2.47% | 8,948,574 | $36.9M | Reduce -3.3% |
| EXAS Exact Sciences Corp. | 2.44% | 650,000 | $36.5M | No change |
| ALNY Alnylam Pharmaceuticals Inc. | 2.20% | 140,000 | $32.9M | Reduce -17.6% |
| BEAM Beam Therapeutics Inc. | 2.07% | 1,250,000 | $31.0M | Add +61.3% |
| NGNE Neurogene Inc. | 1.98% | 1,295,361 | $29.6M | Add +146.9% |
| BPMC Blueprint Medicines Corp. | 1.90% | 326,378 | $28.5M | No change |
| NTLA Intellia Therapeutics Inc. | 1.56% | 2,000,000 | $23.3M | No change |
| VERV Verve Therapeutics Inc. | 1.51% | 3,995,571 | $22.5M | No change |
| DNLI Denali Therapeutics Inc. | 1.35% | 990,000 | $20.2M | No change |
| GPCR Structure Therapeutics Inc. | 1.27% | 700,000 | $19.0M | No change |
| SEPN Septerna Inc. | 0.85% | 553,268 | $12.7M | New |
| VCYT Veracyte Inc. | 0.73% | 276,308 | $10.9M | Reduce -58.5% |
| GH Guardant Health Inc. | 0.71% | 350,000 | $10.7M | No change |
| TNYA Tenaya Therapeutics Inc. | 0.64% | 6,732,971 | $9.6M | No change |
| AGIO Agios Pharmaceuticals Inc. | 0.55% | 250,000 | $8.2M | New |
| MRNA Moderna Inc. | 0.49% | 175,000 | $7.3M | New |
| FDMT 4D Molecular Therapeutics Inc. | 0.43% | 1,150,000 | $6.4M | No change |
| SNDX Syndax Pharmaceuticals Inc. | 0.42% | 475,000 | $6.3M | No change |
| TSVT 2SEVENTY Bio Inc. | 0.39% | 2,000,000 | $5.9M | No change |
| IPSC Century Therapeutics Inc. | 0.35% | 5,190,506 | $5.2M | Add +61.6% |
| FTRE Fortrea Holdings Inc. | 0.34% | 275,000 | $5.1M | New |
| CTNM Contineum Therapeutics Inc. Class A | 0.29% | 296,666 | $4.3M | No change |
| TNGX Tango Therapeutics Inc. | 0.25% | 1,188,349 | $3.7M | No change |
| ABSI Absci Corp. | 0.17% | 973,260 | $2.5M | No change |
| PACB Pacific Biosciences of Calif | 0.13% | 1,035,859 | $1.9M | No change |
| RXRX Recursion Pharmaceuticals-A | 0.07% | 165,323 | $1.1M | New |
| PRME Prime Medicine Inc. | 0.07% | 367,175 | $1.1M | No change |
| GLUE Monte Rosa Therapeutics Inc. | 0.04% | 86,014 | $597K | No change |
| DNA Ginkgo Bioworks Holdings Inc. | 0.02% | 36,493 | $358K | No change |
| KRON Kronos Bio Inc. | 0.01% | 123,839 | $118K | No change |